Francesco Curra
Technik-/Wissenschafts-/F&E-Leiter bei Cerevast Medical, Inc.
Profil
Francesco Curra founded Novuson Surgical, Inc. in 2014, where he worked as Director & Chief Technology Officer from 2014 to 2017.
Dr. Curra also currently works at Cerevast Medical, Inc., as Chief Technology Officer from 2018 and Longevity Biomedical, Inc., as Chief Technology Officer.
Dr. Curra received his doctorate degree from the University of Washington and undergraduate degree from Syracuse University.
Aktive Positionen von Francesco Curra
| Unternehmen | Position | Beginn |
|---|---|---|
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2018 |
Ehemalige bekannte Positionen von Francesco Curra
| Unternehmen | Position | Ende |
|---|---|---|
Novuson Surgical, Inc.
 Novuson Surgical, Inc. Medical SpecialtiesHealth Technology Novuson Surgical, Inc. manufactures surgical devices. It develops a hemostatic platform technology for ablating tissue, isolating tumors, and providing hemostatic control prior to and during surgery. The company was founded by Stuart B. Mitchell in February 2014 and is headquartered in Bothell, WA. | Gründer | 01.08.2017 |
Ausbildung von Francesco Curra
| Syracuse University | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cerevast Medical, Inc.
Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
Novuson Surgical, Inc.
Novuson Surgical, Inc. Medical SpecialtiesHealth Technology Novuson Surgical, Inc. manufactures surgical devices. It develops a hemostatic platform technology for ablating tissue, isolating tumors, and providing hemostatic control prior to and during surgery. The company was founded by Stuart B. Mitchell in February 2014 and is headquartered in Bothell, WA. | Health Technology |
